Delayed
Other stock markets
|
5-day change | 1st Jan Change | ||
1.58 CAD | -1.86% | -4.24% | -52.84% |
May. 14 | Transcript : Aptose Biosciences Inc., Q1 2024 Earnings Call, May 14, 2024 | |
May. 14 | Aptose Biosciences Q1 Net Loss Falls, on Lower Expenses | MT |
This article is reserved for members
Already a member?
Log InNot a member ?
Free registrationEPS Revisions
1st Jan change | Capi. | |
---|---|---|
-51.94% | 19.29M | |
+41.79% | 54.04B | |
+46.17% | 41.96B | |
-0.56% | 41.92B | |
-7.20% | 28.35B | |
+12.59% | 26.35B | |
-21.51% | 19B | |
+6.92% | 13B | |
+29.60% | 12.28B | |
+24.91% | 12.19B |
- Stock Market
- Equities
- APS Stock
- News Aptose Biosciences Inc.
- Aptose Biosciences Brief: Presenting Highlights from Clinical Update Webcast Featuring Latest Available Data on AML Drug Tuspetinib